KEGG: spo:SPBP19A11.02c
STRING: 4896.SPBP19A11.02c.1
SPBP19A11.02c exhibits a unique temporal pattern of expression during meiosis. While the gene is transcribed in proliferating, early, and late meiotic cells with a notable decrease in mid-meiosis, RNA accumulation is observed primarily at late time points in the meiotic process. This distinctive expression profile differentiates it from most meiotic genes, suggesting specialized regulatory mechanisms controlling its expression .
According to quantitative analyses, SPBP19A11.02c demonstrates high mRNA levels (1480.10) with relatively high RNA polymerase II occupancy (1.89), resulting in an mRNA/Pol II ratio of 782.50. This ratio ranks it at position 847 among analyzed genes. Unlike many early meiotic genes, SPBP19A11.02c shows detectable RNA accumulation at the 0-hour timepoint (indicated as "Y" in expression analyses), but lacks a Determinant of Selective Removal (DSR) element that is present in some meiotic genes .
Expression analysis of SPBP19A11.02c typically employs multiple complementary approaches:
Semi-quantitative RT-PCR for temporal expression patterns
Real-time RT-PCR (qRT-PCR) for precise quantification
Microarray analysis for genome-wide expression comparisons
RNA polymerase II occupancy assays to measure transcriptional activity
Northern blot analysis for validation of RNA size and abundance
For comprehensive characterization, these methods should be combined to distinguish between transcriptional and post-transcriptional regulatory mechanisms affecting SPBP19A11.02c expression .
While SPBP19A11.02c remains classified as an uncharacterized protein, computational analyses based on sequence homology and structural predictions suggest potential functional domains. Researchers investigating this protein should perform detailed bioinformatic analyses including:
Protein sequence alignment with characterized proteins from related species
Secondary structure prediction using algorithms such as PSIPRED
Identification of conserved motifs using MEME Suite or similar tools
Domain prediction using InterProScan, Pfam, and SMART databases
Subcellular localization prediction using tools like WoLF PSORT
These analyses can provide initial insights into functional characteristics while experimental validation is pending.
Recombinant expression of SPBP19A11.02c can be accomplished through protocols similar to those used for other S. pombe proteins. A recommended approach includes:
Gene synthesis or PCR amplification from S. pombe genomic DNA
Cloning into an appropriate expression vector (pET, pGEX, or similar) with His or other affinity tags
Expression in E. coli BL21(DE3) or similar strains
Optimization of expression conditions (temperature, IPTG concentration, time)
Purification using affinity chromatography followed by size exclusion
For challenging expression, alternative systems including S. pombe expression systems may be considered to ensure proper post-translational modifications. Protein should be stored in Tris/PBS-based buffer with 6% trehalose at pH 8.0, with aliquoting and addition of 30-50% glycerol for long-term storage at -80°C .
The transcriptional regulation of SPBP19A11.02c during meiosis appears to involve multiple regulatory mechanisms. Based on related meiotic gene studies, several factors likely contribute:
Temporal control via meiosis-specific transcription factors
Chromatin remodeling events specific to the meiotic program
Absence of the DSR element, distinguishing it from many early meiotic genes
Potential regulation by the Mmi1 pathway, which controls numerous meiotic transcripts
Possible involvement of RNA polymerase II occupancy dynamics
The unique expression pattern of transcription throughout the meiotic process but accumulation only during late meiosis suggests post-transcriptional regulation plays a crucial role in controlling SPBP19A11.02c expression .
The absence of a Determinant of Selective Removal (DSR) element in SPBP19A11.02c differentiates it from many other meiotic genes that contain this regulatory element. This has significant implications:
DSR-containing transcripts are typically targeted by the Mmi1 protein for degradation during vegetative growth
The absence of a DSR suggests SPBP19A11.02c may employ alternative mechanisms to regulate its expression
This may explain why SPBP19A11.02c shows RNA accumulation at 0-hour timepoints, unlike DSR-containing genes
The absence of DSR-mediated regulation may contribute to its unique temporal expression pattern
Research methodologies for studying DSR-independent regulation should include RNA stability assays and identification of alternative regulatory elements
While specific data on SPBP19A11.02c polyadenylation is not directly provided in the available research, studies on related meiotic genes in S. pombe have revealed that multiple polyadenylation sites are common features. Research approaches to characterize SPBP19A11.02c polyadenylation should include:
RT-PCR with oligo(dT) as the 3′ primer and gene-specific 5′ primers
Sequencing of cDNAs to map the precise sites of poly(A) addition
Analysis of 3′ UTR lengths in different meiotic stages
Comparison with average S. pombe 3′ UTR length (approximately 169 nucleotides)
Assessment of differential polyadenylation site usage during meiotic progression
Based on related meiotic genes, SPBP19A11.02c may exhibit stage-specific polyadenylation patterns that contribute to its unique expression profile .
The nuclear exosome, particularly the Rrp6 component, plays a crucial role in regulating meiotic gene expression in S. pombe. For SPBP19A11.02c research, the following methodological approaches are recommended:
Analysis of SPBP19A11.02c RNA levels in rrp6Δ mutant strains
Comparison of polyadenylation patterns between wild-type and exosome-deficient cells
Assessment of sensitivity to Mmi1 pathway perturbation
Investigation of potential correlation between exosome sensitivity and temporal expression
Analysis of nuclear versus cytoplasmic RNA distribution to determine compartment-specific degradation
These experiments would help determine whether SPBP19A11.02c is subject to exosome-mediated RNA degradation despite lacking a conventional DSR element .
For effective detection of endogenous or recombinant SPBP19A11.02c protein in research settings, consider these methodological approaches:
Generation of specific antibodies against SPBP19A11.02c by:
Expressing recombinant fragments as antigens
Peptide synthesis based on predicted antigenic regions
Validation using knockout/knockdown controls
Epitope tagging strategies:
C-terminal or N-terminal tagging with HA, Myc, or FLAG
CRISPR-Cas9 genome editing for endogenous tagging
Verification that tags do not disrupt protein function
Detection methods:
Western blotting with optimized extraction buffers for S. pombe
Immunofluorescence microscopy for localization studies
Chromatin immunoprecipitation (ChIP) if nuclear functions are suspected
Mass spectrometry for identification of interaction partners
Controls and validation:
Use of knockout strains as negative controls
Recombinant protein as positive control
Synchronization of meiotic cultures for temporal studies
A comprehensive functional characterization strategy for SPBP19A11.02c should include:
Gene deletion/disruption:
Construction of knockout strains using homologous recombination
Phenotypic analysis focusing on meiotic progression and sporulation
Complementation assays to confirm phenotype specificity
Temporal expression manipulation:
Implementation of controllable promoters (nmt1, urg1)
Analyses of effects of premature expression or repression
Assessment of dose-dependent phenotypes
Protein interaction studies:
Yeast two-hybrid screening
Affinity purification coupled with mass spectrometry
Co-immunoprecipitation assays during different meiotic stages
Proximity labeling approaches (BioID, APEX)
Localization studies:
Live-cell imaging with fluorescent protein fusions
Cell fractionation followed by Western blotting
Colocalization with known meiotic markers
RNA-protein interaction analysis if RNA-binding properties are suspected:
RNA immunoprecipitation (RIP)
Crosslinking and immunoprecipitation (CLIP) methods
A comparative analysis between SPBP19A11.02c and other late meiotic genes reveals distinctive characteristics:
| Gene name | Systematic name | 0 h accumulation | mRNA level | Pol II occupancy | mRNA/Pol II | Rank | DSR? |
|---|---|---|---|---|---|---|---|
| SPBP19A11.02c | SPBP19A11.02c | Y | 1480.10 | 1.89 | 782.50 | 847 | N |
| act1 | SPBC32H8.12c | Y | 12,327.21 | 6.90 | 1786.94 | 2452 | N |
| atg8 | SPBP8B7.24c | Y | 909.20 | 1.32 | 688.53 | 718 | N |
| mug142 | SPBC3H7.09 | Y | 963.25 | 0.97 | 998.19 | 1220 | N |
| SPAC1039.11c | SPAC1039.11c | Y | 1299.55 | 0.57 | 2285.93 | 3059 | N |
| SPAC1610.02c | SPAC1610.02c | Y | 2541.95 | 0.98 | 2599.13 | 3377 | N |
This comparison highlights that SPBP19A11.02c has:
High mRNA levels comparable to other late meiotic genes
Higher Pol II occupancy than most late genes
A mRNA/Pol II ratio that suggests moderate post-transcriptional regulation
Absence of a DSR element, consistent with most late meiotic genes
To specifically determine the function of SPBP19A11.02c among other uncharacterized S. pombe proteins, researchers should employ:
Comparative phenotypic analysis:
Creation of a deletion strain library of multiple uncharacterized proteins
Systematic phenotypic screening under various conditions (nutritional stress, DNA damage, meiotic induction)
Quantitative fitness measurements and genetic interaction mapping
Temporal coordination studies:
High-resolution time-course analysis during meiosis
Correlation of expression patterns with known meiotic events
Identification of co-regulated gene clusters
Evolutionary analysis:
Comparison with orthologs in related fission yeast species
Assessment of conservation levels across different domains
Identification of species-specific adaptations
Multi-omics integration:
Correlation of transcriptomic, proteomic, and metabolomic data
Network analysis to position SPBP19A11.02c in relevant pathways
Identification of unique regulatory signatures
Synthetic genetic interactions:
Synthetic genetic array (SGA) analysis
Targeted double mutant construction with known meiotic regulators
Chemical-genetic profiling to identify functional pathways
Researchers working with recombinant SPBP19A11.02c may encounter several technical challenges:
Protein insolubility:
Optimize expression temperature (try 18°C, 25°C, 30°C)
Use solubility-enhancing fusion partners (MBP, SUMO, Thioredoxin)
Test different buffer compositions with varying salt concentrations and pH
Consider mild detergents for membrane-associated proteins
Low expression yield:
Optimize codon usage for E. coli or alternative expression hosts
Test different E. coli strains (BL21, Rosetta, Arctic Express)
Consider S. pombe expression systems for authentic post-translational modifications
Use auto-induction media instead of IPTG induction
Protein instability:
Add protease inhibitors during purification
Include stabilizing agents (glycerol, trehalose, specific metal ions)
Optimize storage conditions (buffer composition, pH, temperature)
Consider flash-freezing aliquots to prevent freeze-thaw degradation
Functional characterization difficulties:
Ensuring antibody specificity is critical for reliable SPBP19A11.02c research. A comprehensive validation protocol should include:
Preliminary validation:
Western blot against recombinant protein
Comparison of signal in wild-type vs. deletion strains
Pre-absorption test with purified antigen
Specificity controls:
Testing antibody against lysates from overexpression strains
Peptide competition assays
Screening against closely related proteins
Application-specific validation:
For immunoprecipitation: verification of pulled-down protein by mass spectrometry
For immunofluorescence: comparison with GFP-tagged protein localization
For ChIP: validation with tagged protein ChIP and appropriate controls
Cross-reactivity assessment:
Testing against lysates from related yeast species
Epitope mapping to identify potential cross-reactive regions
Dilution series to determine optimal working concentration
Documentation:
Detailed recording of antibody source, lot number, and validation experiments
Sharing validation data in publications and repositories
Several cutting-edge technologies could significantly enhance our understanding of SPBP19A11.02c:
CRISPR-Cas9 applications:
Precise genome editing for functional domain mapping
CRISPRi for temporal knockdown studies
Base editing for introduction of specific mutations
Prime editing for precise sequence modifications
Advanced microscopy:
Super-resolution microscopy for detailed localization
Live-cell single-molecule tracking
Correlative light and electron microscopy (CLEM)
Lattice light-sheet microscopy for long-term imaging
Structural biology approaches:
Cryo-electron microscopy for protein structure determination
Integrative structural biology combining multiple data sources
Hydrogen-deuterium exchange mass spectrometry for dynamics
AlphaFold2 and other AI-based structure prediction tools
Single-cell technologies:
Single-cell RNA-seq during meiotic progression
Single-cell proteomics for protein abundance measurement
Spatial transcriptomics for localization of expression
Multi-modal single-cell analysis
Systems biology approaches:
Multi-omics data integration
Network modeling of meiotic regulation
Perturbation analysis using combinatorial genetic modifications
Mathematical modeling of expression dynamics
When facing contradictory data regarding SPBP19A11.02c function, researchers should implement systematic approaches to resolve discrepancies:
Standardization of experimental conditions:
Establish unified protocols for meiotic synchronization
Standardize growth conditions and media composition
Use consistent strain backgrounds for comparability
Implement precise timing for sample collection
Methodological cross-validation:
Apply multiple independent techniques to measure the same parameter
Validate observations across different experimental platforms
Compare results from different detection methods (antibody vs. tag-based detection)
Reproduce key findings in different laboratories
Genetic background considerations:
Test for strain-specific effects by using multiple S. pombe isolates
Construct clean genetic backgrounds to minimize confounding mutations
Consider heterogeneity in lab strains due to accumulated mutations
Context-dependent function analysis:
Systematically test function under different environmental conditions
Evaluate meiotic stage-specific activities
Investigate potential redundancy with other proteins
Analyze genetic interactions that may mask phenotypes
Meta-analysis approach:
Compile all available data with detailed experimental parameters
Weight evidence based on methodological rigor
Develop testable hypotheses that could explain apparent contradictions
Design decisive experiments targeting the most likely explanations